Industry & Services >> Analyst Interviews >> October 8, 2001

Instrument Industry Outlook: Paul Knight – Thomas Weisel Partners

PAUL R. KNIGHT, CFA, is a Founding Partner of Thomas Weisel Partners LLC, co-Head of Healthcare Research, and Head of the Life Science Research Group. Prior to his position at Thomas Weisel Partners, Mr. Knight spent 11 years at Salomon Brothers and NatWest Securities. Over his 14-year Wall Street career, he has been a top-ranked analyst by Institutional Investor, The Greenwich Survey and The Wall Street Journal. For 10 years, Mr. Knight has been ranked as having the best Buy or Sell stock ratings, most recently in the 2000 and 2001 Wall Street Journal surveys. He is a Chartered Financial Analyst and has received a BS in Economics from the University of Nebraska and an MBA from the George Washington University. Profile
TWST: What is the broad definition of your coverage area?

Mr. Knight: I was the first analyst on Wall Street to cover instrument

stocks and the instrument industry as a discrete investment